Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology

Author:

Yaegashi HirokoORCID,Hayashi Yukikazu,Takeda Makoto,Chiu Shih-Wei,Nakayama Haruhiko,Ito Hiroyuki,Takano Atsushi,Tsuboi Masahiro,Teramoto Koji,Suzuki Hiroyuki,Kato Tatsuya,Yasui Hiroshi,Nagamura Fumitaka,Daigo Yataro,Yamaguchi Takuhiro

Abstract

Abstract Background Clinical trials have become larger and more complex. Thus, eSource should be used to enhance efficiency. This study aimed to evaluate the impact of the multisite implementation of eSource direct data capture (DDC), which we define as eCRFs for direct data entry in this study, on efficiency by analyzing data from a single investigator-initiated clinical trial in oncology. Methods Operational data associated with the targeted study conducted in Japan was used to analyze time from data occurrence to data entry and data finalization, and number of visits to the site and time spent at the site by clinical research associates (CRAs). Additionally, simulations were performed on the change in hours at the clinical sites during the implementation of eSource DDC. Results No difference in time from data occurrence to data entry was observed between the DDC and the transcribed data fields. However, the DDC fields could be finalized 4 days earlier than the non-DDC fields. Additionally, although no difference was observed in the number of visits for source data verification (SDV) by CRAs, a comparison among sites that introduced eSource DDC and those that did not showed that the time spent at the site for SDV was reduced. Furthermore, the simulation results indicated that even a small amount of data to be collected or a small percentage of DDC-capable items may lead to greater efficiency when the number of subjects per site is significant. Conclusions The implementation of eSource DDC may enhance efficiency depending on the study framework and type and number of items to be collected.

Publisher

Springer Science and Business Media LLC

Reference7 articles.

1. International Council for Harmonization. Integrated addendum to ICH E6(R1): guideline for good clinical practice E6(R2). 2016. https://database.ich.org/sites/default/files/E6_R2_Addendum.pdf. Accessed Sept 2023.

2. Getz KA, Campo RA. New benchmarks characterizing growth in protocol design complexity. Ther Innov Regul Sci. 2018;52:22–8. https://doi.org/10.1177/2168479017713039.

3. Kellar E, Bornstein SM, Caban A, et al. Optimizing the use of electronic data sources in clinical trials: the landscape, part 1. Ther Innov Regul Sci. 2016;50:682–96. https://doi.org/10.1177/2168479016670689.

4. Kellar E, Bornstein S, Caban A, et al. Optimizing the use of electronic data sources in clinical trials: the technology landscape. Ther Innov Regul Sci. 2017;51:551–67. https://doi.org/10.1177/2168479017718875.

5. European Medicines Agency. Qualification opinion on eSource direct data capture (DDC). https://www.ema.europa.eu/documents/regulatory-procedural-guideline/qualification-opinion-esource-direct-data-capture-ddc_en.pdf. Accessed Sept 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3